Jubilant Ingrevia Ltd is Rated Hold

1 hour ago
share
Share Via
Jubilant Ingrevia Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.
Jubilant Ingrevia Ltd is Rated Hold

Understanding the Current Rating

The 'Hold' rating assigned to Jubilant Ingrevia Ltd indicates a balanced outlook for the stock. It suggests that investors should maintain their existing positions rather than aggressively buying or selling. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential in the specialty chemicals sector.

Quality Assessment

As of 12 June 2026, Jubilant Ingrevia Ltd holds an average quality grade. The company demonstrates a strong ability to service its debt, with a low Debt to EBITDA ratio of 1.40 times, signalling prudent financial management and manageable leverage. Additionally, the debt-equity ratio stands at a conservative 0.25 times as per the half-year data, further underscoring the company’s stable capital structure. However, the long-term growth outlook remains subdued, with net sales declining at an annualised rate of -2.96% and operating profit contracting by -13.79% over the past five years. Despite these challenges, the company maintains a robust operating profit to interest coverage ratio of 13.77 times, reflecting healthy earnings relative to interest expenses.

Valuation Perspective

Jubilant Ingrevia Ltd’s valuation is currently attractive. The stock trades at an enterprise value to capital employed ratio of 2.8, which is below the average historical valuations of its peers in the specialty chemicals sector. This discount suggests that the market may be undervaluing the company relative to its capital base. The return on capital employed (ROCE) is a respectable 10.5%, indicating efficient use of capital to generate profits. Furthermore, despite the stock delivering a negative return of -9.75% over the past year, the company’s profits have risen by 14.4% during the same period. This divergence between stock price and earnings growth results in a PEG ratio of 2.4, signalling moderate growth expectations relative to valuation.

Financial Trend Analysis

The financial trend for Jubilant Ingrevia Ltd is positive as of 12 June 2026. While the company has faced headwinds in sales growth over the last five years, recent quarterly data shows net sales reaching a high of ₹1,178.65 crores, indicating potential stabilisation or recovery. Profitability metrics have improved, with operating profits rising despite the broader challenges in the sector. Institutional investors hold a significant stake of 31.27%, and their holdings have increased by 1.1% over the previous quarter. This uptick in institutional interest often reflects confidence in the company’s fundamentals and future prospects, providing a supportive backdrop for the stock.

Technical Outlook

From a technical standpoint, Jubilant Ingrevia Ltd is exhibiting a sideways trend. The stock’s price movement over the short to medium term has been relatively range-bound, with a 1-day gain of 1.26% and a modest 0.11% increase over the past week. However, the stock has experienced volatility, with a 1-month decline of -12.28% and a 6-month drop of -9.82%. Year-to-date, the stock is down by -10.98%, and over the last year, it has declined by -8.30%. These fluctuations suggest that while the stock is not currently in a strong uptrend, it is also not in a pronounced downtrend, reinforcing the 'Hold' stance for investors awaiting clearer directional signals.

Implications for Investors

For investors, the 'Hold' rating on Jubilant Ingrevia Ltd implies a cautious approach. The company’s attractive valuation and improving financial trends offer some upside potential, but the average quality grade and sideways technical pattern suggest limited immediate catalysts for significant price appreciation. Investors should monitor upcoming quarterly results and sector developments closely, as any sustained improvement in sales growth or profitability could warrant a reassessment of the stock’s outlook. Conversely, continued stagnation or deterioration in fundamentals may prompt a more conservative stance.

Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?

  • - Building momentum strength
  • - Investor interest growing
  • - Limited time advantage

Join the Momentum →

Sector and Market Context

Jubilant Ingrevia Ltd operates within the specialty chemicals sector, a space characterised by cyclical demand and sensitivity to raw material prices and regulatory changes. The company’s small-cap status means it may be more susceptible to market volatility compared to larger peers. However, its strong institutional backing and disciplined financial management provide a degree of resilience. Investors should consider sector trends, including global chemical demand and supply chain dynamics, when evaluating the stock’s prospects.

Summary of Key Metrics as of 12 June 2026

To summarise, the stock’s key metrics include a Mojo Score of 64.0, reflecting a moderate investment appeal consistent with the 'Hold' rating. The company’s debt metrics remain conservative, with a Debt to EBITDA ratio of 1.40 times and a debt-equity ratio of 0.25 times. Profitability is improving, with a 14.4% increase in profits over the past year despite a decline in stock price. The PEG ratio of 2.4 suggests moderate growth expectations relative to valuation. Institutional holdings at 31.27% indicate strong investor confidence. Technically, the stock is range-bound, with recent price movements showing limited directional momentum.

Conclusion

In conclusion, Jubilant Ingrevia Ltd’s 'Hold' rating by MarketsMOJO reflects a balanced view of the company’s current standing. Investors are advised to maintain their positions while closely monitoring financial performance and market conditions. The stock’s attractive valuation and improving financial trends offer potential, but the average quality and sideways technical pattern counsel prudence. This rating serves as a guide for investors seeking to navigate the complexities of the specialty chemicals sector with a measured approach.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News